Trends of Mortality in End-Stage Liver Disease — China, 2008–2020

Xiaoxiao Wang(Peking University), Maigeng Zhou(National Center for Chronic and Noncommunicable Disease Control and Prevention), Yunning Liu(National Center for Chronic and Noncommunicable Disease Control and Prevention), Huiying Rao(Peking University), Jiangmei Liu(Chinese Center For Disease Control and Prevention), Fangfang Zeng(Sun Yat-sen University), Jinlei Qi(National Center for Chronic and Noncommunicable Disease Control and Prevention), Feng Liu(Women's Health Research Institute), Yu Wang(China Foundation for Hepatitis Prevention and Control), Lai Wei(Tongji University), Peng Yin(National Center for Chronic and Noncommunicable Disease Control and Prevention), Xiaofeng Liang(Cairo University), Hongbo Li(Nanchang University), Lijun Wang(National Center for Chronic and Noncommunicable Disease Control and Prevention), Huixin Liu(Peking University)
China CDC Weekly
January 1, 2023
10.46234/ccdcw2023.128
Cited by 8

Related Papers

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
|The Lancet|2015|6.5k
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k
Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013
|The Lancet|2015|1.5k
Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2021|899